Skip to main content
OpenTrials
Completed

NCT Number: NCT07532668

Multicentre Retrospective Cohort Study of Palliative Care Pathways in Patients Who Died From Sarcoma

The goal of this observational study is to describe palliative pathways in adult patients who died from their sarcoma.

The main question it aims to answer is:

How patients who died from sarcoma are followed by palliative team.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Sarcoma Death Neoplasms Neoplasms by Histologic Type Neoplasms, Connective and Soft Tissue Pathologic Processes Pathological Conditions, Signs and Symptoms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Centre Leon Berard

Lyon, France

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Oncology follow up in Centre Léon Bérard, or Institut Gustave Roussy, or Institut Curie
  • sarcoma histology confirmed
  • >18 years at diagnosis
  • death between 01/01/2024 ans 31/12/2024
  • death related to sarcoma

Exclusion criteria

  • >1 year between last follow up in Centre Léon Bérard, or Institut Gustave Roussy, or Institut Curie and death
  • patient opposed to the collect of data

Treatment and study plan

Primary outcomes

  1. Palliative pathways of patients who died from sarcoma

    Time frame: From date of inclusion until the date of death from any cause, assessed up to 42 months

    Palliative pathways will be described using the proportion of patients with each of the following component :

    • hospitalisation in a palliative care unit,
    • consultation with palliative care doctor,
    • mobile palliative care team advice We collect data on the first and last time of each kind of palliative follow up, we collect the number of day between the meeting and death For exemple: palliative care unit: first meeting 200 days before death and last meeting 80 days before death

Secondary outcomes

  1. Treatment with chemotherapy in the last 14 days of life

    Time frame: From date of inclusion until the date of death from any cause, assessed up to 42 months

    Percentage and number of patients having a treatment with chemotherapy in the last 14 days of life

  2. More than 1 visit in an emergency unit in the last 30 days of life

    Time frame: From date of inclusion until the date of death from any cause, assessed up to 42 months

    Percentage and number of patients having more than 1 visit in an emergency unit in the last 30 days of life

  3. Hospitalization in a resuscitation unit in the last 30 days of life

    Time frame: From date of inclusion until the date of death from any cause, assessed up to 42 months

    Percentage and number of patients having a hospitalization in a resuscitation unit in the last 30 days of life

  4. More than 1 hospitalization in the last 30 days of life

    Time frame: From date of inclusion until the date of death from any cause, assessed up to 42 months

    Percentage and number of patients having more than 1 hospitalization in the last 30 days of life

  5. Less than 3 days in palliative care unit

    Time frame: From date of inclusion until the date of death from any cause, assessed up to 42 months

    Percentage and number of patients having a hospitalization in a palliative care unit less than three days before death

  6. New chemotherapy regimen starting in the last 30 days of life

    Time frame: From date of inclusion until the date of death from any cause, assessed up to 42 months

    Percentage and number of patients having a new chemotherapy regimen starting in the last 30 days of life

  7. Place of death

    Time frame: At the date of death from any cause, assessed up to 42 months

    Hospital and type of unit or home will be described

Sponsors and collaborators

Lead sponsor

Centre Leon Berard

Other

Collaborators

  • Gustave Roussy, Cancer Campus, Grand Paris
  • Institut Curie

Registry information

Acronym: SARCOPALL

Important dates

Study start
2024
Primary completion
2024
Study completion
2024
First posted
Apr 16, 2026
Registry last updated
Apr 16, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.